Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice. - Trial NCT06015594
Access comprehensive clinical trial information for NCT06015594 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Cagliari and is currently Completed. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 168 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Cagliari
Timeline & Enrollment
N/A
Jan 01, 2015
May 01, 2022
Primary Outcome
Insulin resistance change in eighty hyperinsulinemic patients after metformin therapy and its discontinuation,Androgen levels change in eighty hyperinsulinemic patients after metformin therapy and its discontinuation
Summary
This study aimed to understand whether metformin therapy can improve insulin resistance in
 adolescent PCOS patients, both during treatment and after discontinuation, and to evaluate
 its action on the hormonal and metabolic pathways.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06015594
Non-Device Trial